Tune Therapeutics Unveils Breakthrough Data ShowingStable and Durable Epigenetic Regulation in Non-Human Primates

Method targets the epigenome, makes no changes to the underlying DNA sequence First example of lasting repression after transient epi-editor delivery in a non-human primate DURHAM, N.C. and SEATTLE, WA -(BUSINESS WIRE)- May 22, 2023 – Last week, at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT), leading epigenetic editing company Tune Therapeutics showcased the […]